for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Eli Lilly bowel disease treatment succeeds in late-stage study

March 16 - Eli Lilly and Co said on Tuesday its experimental treatment for an inflammatory bowel disease succeeded in a late-stage trial.

The drug, mirikizumab, met the main goal of showing reduced bowel urgency in moderate to severe ulcerative colitis. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up